SERPINE1 and breast carcinoma: Others have linked PAI-1 to poor prognosis in OC patients (Peng et al., 2019; Teliga-Czajkowska et al., 2019), and have also shown that elevated baseline plasma PAI-1 is a predictor of relapse in breast cancer (BC) patients (Ferroni et al., 2014).